Hepatic metastases resection after cetuximab: are we missing something?

Ulusakarya, Ayhan; Innominato, Pasquale F; Bouchahda, Mohamed; Levi, Francis A; Adam, René

Ulusakarya, Ayhan; Innominato, Pasquale F; Bouchahda, Mohamed; Levi, Francis A; Adam, René.

Afiliação

Ulusakarya A; Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France. Electronic address: ayhan.ulusakarya@aphp.fr.
Innominato PF; INSERM U935 Campus CNRS, Villejuif, France; North Wales Cancer Centre, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, UK; Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry, UK.
Bouchahda M; Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France.
Levi FA; Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France; Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry, UK.
Adam R; Centre Hépato-Biliaire, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France.

Lancet Oncol ; 21(5): e228, 2020 05.

Article em En | MEDLINE | ID: mdl-32359493

Assuntos

Neoplasias Colorretais; Neoplasias Hepáticas; Camptotecina; Cetuximab; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google